MeSH D014917 - whooping cough
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Erythromycin | C-solve |  | 1993-07-30 |  |  |
| Erythromycin | Erythromycin |  | 2021-02-11 |  |  | |
| Erythromycin estolate | Erythromycin Estolate |  | 1982-01-01 |  |  | |
| Erythromycin lactobionate | Erythromycin Lactobionate |  | 1993-07-30 |  |  | |
| Padagis | Erythromycin | Erythromycin |  | 1983-09-26 |  |  |
| Taro Pharmaceutical | Erythromycin | A/t/s |  | 1982-11-18 |  |  |
| Mylan | Erythromycin | E-glades |  | 2002-03-18 |  |  |
| Erythromycin | Erygel |  | 1987-10-21 |  |  | |
| Erythromycin | Erythromycin |  | 1996-07-03 |  |  | |
| Erythromycin stearate | Erythromycin Stearate |  | 1982-01-01 |  |  | |
| Johnson & Johnson | Erythromycin | Erycette |  | 1985-02-15 |  |  |
| Perrigo | Guaifenesin | Guaifenesin |  | 2011-11-23 |  |  |
| Dextromethorphan, Guaifenesin | Guaifenesin Dextromethorphan |  | 2018-03-05 |  |  | |
| Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2022-02-01 |  |  | |
| Wyeth | Erythromycin, Erythromycin stearate | Wyamycin |  | 1982-01-01 |  |  |
| Alpharma | Erythromycin | Erythromycin |  | 1982-04-19 |  |  |
| Erythromycin estolate | Erythromycin Estolate |  | 1982-11-18 |  |  | |
| Erythromycin | Erythromycin Ethylsuccinate |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
80%4/5
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use